NCT02183337View on ClinicalTrials.gov

Bioavailability of BI 1356 With and Without Co-administration of Pioglitazone and the Bioavailability of Pioglitazone With and Without Coadministration of BI 1356 in Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

April 30, 2007

Conditions
Healthy
Interventions
DRUG

BI 1356

DRUG

BI 1356 + Pioglitazone

DRUG

Pioglitazone

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02183337 - Bioavailability of BI 1356 With and Without Co-administration of Pioglitazone and the Bioavailability of Pioglitazone With and Without Coadministration of BI 1356 in Healthy Male and Female Volunteers | Biotech Hunter | Biotech Hunter